(Q30858811)

English

Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 November 2017

Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial (English)

1 reference

Europe PubMed Central

13 November 2017

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Deborah Donnell

2

1 reference

Europe PubMed Central

13 November 2017

object named as

Allan Ronald

12

0 references

11

object named as

Elly Katabira

1 reference

Europe PubMed Central

13 November 2017

Elizabeth Bukusi

9

object named as

Elizabeth A Bukusi

1 reference

Europe PubMed Central

13 November 2017

10

object named as

Craig R Cohen

1 reference

Europe PubMed Central

13 November 2017

Grace John-Stewart

18

object named as

Grace John-Stewart

1 reference

Europe PubMed Central

13 November 2017

Jordan W Tappero

8

object named as

Jordan W Tappero

1 reference

Europe PubMed Central

13 November 2017

17

object named as

Carey Farquhar

1 reference

Europe PubMed Central

13 November 2017

23

object named as

Lisa Frenkel

1 reference

Europe PubMed Central

13 November 2017

Robert W Coombs

20

object named as

Robert W Coombs

1 reference

Europe PubMed Central

13 November 2017

1

object named as

Jared M Baeten

1 reference

Europe PubMed Central

13 November 2017

3

object named as

Nelly R Mugo

1 reference

Europe PubMed Central

13 November 2017

Jessica E Haberer

24

object named as

Jessica E Haberer

1 reference

Europe PubMed Central

13 November 2017

19

object named as

Lara Kidoguchi

1 reference

Europe PubMed Central

13 November 2017

Elioda Tumwesigye

13

object named as

Elioda Tumwesigye

1 reference

Europe PubMed Central

13 November 2017

14

object named as

Edwin Were

1 reference

Europe PubMed Central

13 November 2017

author name string

Patrick Ndase

4

1 reference

Europe PubMed Central

13 November 2017

Katherine K Thomas

5

1 reference

Europe PubMed Central

13 November 2017

James D Campbell

6

1 reference

Europe PubMed Central

13 November 2017

Jonathan Wangisi

7

1 reference

Europe PubMed Central

13 November 2017

Kenneth H Fife

15

1 reference

Europe PubMed Central

13 November 2017

James Kiarie

16

1 reference

Europe PubMed Central

13 November 2017

Craig Hendrix

21

1 reference

Europe PubMed Central

13 November 2017

Mark A Marzinke

22

1 reference

Europe PubMed Central

13 November 2017

David Bangsberg

25

1 reference

Europe PubMed Central

13 November 2017

Partners PrEP Study Team

27

1 reference

Europe PubMed Central

13 November 2017

publication date

7 October 2014

1 reference

Europe PubMed Central

13 November 2017

Lancet Infectious Diseases

1 reference

Europe PubMed Central

13 November 2017

14

1 reference

Europe PubMed Central

13 November 2017

11

1 reference

Europe PubMed Central

13 November 2017

1055-1064

1 reference

Europe PubMed Central

13 November 2017

Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the partners PrEP study experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Preexposure prophylaxis for HIV prevention: where have we been and where are we going?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Preexposure prophylaxis for HIV infection among African women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Prevention of HIV-1 infection with early antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Improved Horvitz-Thompson Estimation of Model Parameters from Two-phase Stratified Samples: Applications in Epidemiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

21 June 2018

Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4252589

25 November 2018

Identifiers

10.1016/S1473-3099(14)70937-5

1 reference

Europe PubMed Central

13 November 2017

1 reference

Europe PubMed Central

13 November 2017

1 reference

Europe PubMed Central

13 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30858811&oldid=2117172171"